Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

28. Mai 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1946


	Articles 1 - 20 / 38908

	A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial. ESMO Gastrointest Oncol Okemoto D, Kotani D, Nakamura M, Sato K, Kubo Y, Kadota T, Mishima S, Sakashita S, Hashimoto T, Bando H, Wakabayashi M, Rabinowitz M, Liu MC, Jurdi A, Yamaguchi T, Nishikawa H, Shitara K, Yano T, Kojima T, Fujita T. PMID: 42205796 [PubMed]
	Identification of serum 5'tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer. Sci Rep Zhang L, Zi B, Hong J, Chen Y, Ju S, Jing R, Cui M, Cheng C. PMID: 42204280 [PubMed - as supplied by publisher]
	First-In-Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck. Cancer Sci Matsubara N, Saijo K, Shimizu Y, Okano S, Nakano K, Nishio N, Otsuka T, Kuno H, Miura T, Kubota T, Ikezawa H, Umetsu Y, Ito K, Apfel A, Ye Y, Honma Y. PMID: 42203677 [PubMed - as supplied by publisher]
	Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study. Anticancer Res Lin CY, Lin YS, Fang HY, Wang CC, Liang JA, Li CC, Chien CR. PMID: 42203356 [PubMed - indexed for MEDLINE]
	Value-based pricing of tislelizumab plus chemotherapy versus chemotherapy alone for advanced oesophageal squamous cell carcinoma: a Markov modelling study from the US payer perspective. BMJ Open Abdeen AA, Ayer T, Lim F, Shue S, Hur C. PMID: 42203284 [PubMed - indexed for MEDLINE]
	Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer. N Engl J Med Shitara K, Elimova E, Liu T, Tabernero J, Lee KW, Schenker M, Tebbutt NC, Ajani J, Salimin N, Ku G, Gwang Kim J, Ales Diaz I, Zhang J, Pietrantonio F, Bai LY, Le Sourd S, Zhao J, Hierro C, Kiberu A, Van Herpe F, Bao Y, Zhang H, Yang L, Li V, Gartner EM, Chen Y, Grim J, Rha SY, Shen L, HERIZON-GEA-01 Investigators. PMID: 42202319 [PubMed - indexed for MEDLINE]
	Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study. Ann Surg Oncol Kosumi K, Harada K, Shimogawa T, Tsubakihara H, Hara Y, Matsumoto C, Yamashita K, Ohuchi M, Eto K, Ogawa K, Ida S, Hiyoshi Y, Nagai Y, Baba Y, Miyamoto Y, Yoshida N, Iwatsuki M. PMID: 42201494 [PubMed - as supplied by publisher]
	Prognostic significance of the CRP-albumin-lymphocyte (CALLY) index in esophageal cancer: systematic review and meta-analysis. PeerJ Xu W, Zhan D, Wang R, Jin S, Liu XB. PMID: 42199834 [PubMed - indexed for MEDLINE]
	Hollow Cu(2-x)Se/PDA/IR820 Composite Nanoparticles with pH Response for Multimodal Synergistic Treatment of Esophageal Cancer. Int J Nanomedicine Ma F, Ji A, Ma B, Yang P, Li J, Liao S, Yao H, Xie X, Wang Z, Shi L, Gao S, Hou X. PMID: 42199656 [PubMed - indexed for MEDLINE]
	Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes. Ther Adv Med Oncol Chen M, Huang Y, Liu F, Lin C, Zhang S, Zeng T, Yu J, Zheng B, Chen C. PMID: 42199486 [PubMed]
	Interpretable survival modeling integrating nutritional-inflammatory biomarkers in elderly patients with locally advanced esophageal squamous cell carcinoma treated with definitive radiotherapy. Front Immunol Zou J, Fan W, Xia X, Zhang M, Han T, Wu Q. PMID: 42199434 [PubMed - indexed for MEDLINE]
	First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis. Medicina (Kaunas) Seyyar M, Can , Sakin A, Bayramgil A, Dülgar Kaya Ö, Sünger E, Aç, Demir T, Türkel R, Y, Özalp FR, Semiz HS, Y, Aykan MB, Turhan G, Y, Menek, Kut E, Çakmak M, Alg, , Karakayal, O, Artaç M, , Paçac, Sar, , Guliyev M, Demirci NS, Çavdar E, Elçiçek ÖF, , Bölek H, Kubilay Tolunay P, Kalem A, Yaz, Merç Çetinkaya A, Akba, Biter S, Kitapl, Özkan MK, , Majidova N, Arak H, Y, Çabuk D, Uygun K, Sezgin Göksu S, Tanr, Selçukbiricik F, Uzun M, Ökten , Mete B, Kö, Bilici A, Ku, Dizdar Ö, Yalç, Kefeli U. PMID: 42195237 [PubMed - indexed for MEDLINE]
	State-of-the-Art Mediastinal Staging in Non-Small-Cell Lung Cancer: Integration of Combined Endosonographic Techniques with Updated IASLC TNM 9th Classification. Cancers (Basel) Alkathiri O, Liberman M. PMID: 42193023 [PubMed]
	Efficacy of Spectral-Aided Visual Enhancer in Classification of Esophageal Cancer. Cancers (Basel) Koh KY, Mukundan A, Karmakar R, Atulbhai CT, Chen TH, Weng WC, Wang HC. PMID: 42192971 [PubMed]
	Artificial Intelligence in Oncology: A Comprehensive Cross-Cancer Translational Readiness Analysis Across 18 Malignancies. Cancers (Basel) Kuchana SK, Repalle UK, Alahari NV, Kondamuri M, Manduva SK, Vanguru RV, Gorle SA, Alahari SK. PMID: 42192906 [PubMed]
	A novel mucosal lymphatic vessel classification correlating with histopathology of early esophageal squamous cell carcinoma: A proposed system from China. Chin Med J (Engl) Zhang Y, Peng T, Ye L, Chen L, Yuan X, Yao M, Feng Y, Zeng X, Chen O, Gao Y, Luo Q, Zhu Y, Zhang L, Liu W, Mou Y, He L, Zhou X, Deng Q, Hu B. PMID: 42192218 [PubMed - as supplied by publisher]
	AI-driven multi-omics drug repurposing nominates AZD7762 as a multitarget inhibitor of IL22RA1 and FAM221A in esophageal squamous cell carcinoma. NPJ Precis Oncol Zhuang Z, Yu S, Peng K, Zhang P, Yu J, Lin J, Kang M. PMID: 42191940 [PubMed - as supplied by publisher]
	Endoscopy-based Deep Learning Algorithms versus Endoscopists in Early Esophageal Squamous Cell Carcinoma Detection: A Systematic Review and Meta-Analysis. Am J Gastroenterol Men X, Wang Y, Zhao Y, Zhang H, Zhang X. PMID: 42189588 [PubMed - as supplied by publisher]
	Diagnostic performance of [(18)F]Tetrafluoroborate PET versus (131)I scintigraphy in differentiated thyroid cancer: a prospective study. Eur J Nucl Med Mol Imaging Sonmezoglu K, Sahin OE, Saglam K, Karayel E, Pehlivanoglu H, Uslu-Besli L, Sayman HB. PMID: 42189228 [PubMed - as supplied by publisher]
	Association Between Regional Cardiac Radiation Dose and Magnetic Resonance Imaging Myocardial Contractility Parameters: A Prospective Pilot Study. Tomography Ibrahim EH, Klawikowski S, Puckett L, Gore E, An D, Bychowski J, Sosa A, Walls G, Bergom C. PMID: 42188711 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38908

Page 1 de 1946



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité